Manages chronic stable angina and angina due to coronary artery spasm. ANDA 74185, held by Teva. Diltiazem Hydrochloride.
As of Nov 16, 2026, ANDA 74185 (Diltiazem Hydrochloride), held by Teva, was first approved by FDA on May 31, 1995, with 10 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Diltiazem hydrochloride tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 31, 1995 | Original application | Approved | None posted |
| Diltiazem Hydrochloride30MG · tablet;oral | Diltiazem Hydrochloride | Rx |
| Diltiazem Hydrochloride60MG · tablet;oral | Diltiazem Hydrochloride | Rx |
| Diltiazem Hydrochloride90MG · tablet;oral | Diltiazem Hydrochloride | Rx |
| Diltiazem Hydrochloride120MG · tablet;oral | Diltiazem Hydrochloride | Rx |
| Apr 29, 2020 | Supplement 18Labeling · Standard review | Approved | None posted |
| Apr 29, 2020 | Supplement 21Labeling · Standard review | Approved | None posted |
| Jan 27, 2011 | Supplement 16Labeling | Approved | None posted |
| Dec 2, 1999 | Supplement 11Manufacturing | Approved | None posted |
| Dec 2, 1999 | Supplement 12Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 4Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 5Manufacturing | Approved | None posted |
| Jan 8, 1998 | Supplement 3Manufacturing | Approved | None posted |
| Jun 6, 1997 | Supplement 2Manufacturing | Approved | None posted |
| Jan 24, 1997 | Supplement 1Labeling | Approved | None posted |
| May 31, 1995 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters